Cara Therapeutics, Inc. 4
4 · Cara Therapeutics, Inc. · Filed Jul 6, 2015
Insider Transaction Report
Form 4
Lewis Michael E
Chief Scientific Advisor
Transactions
- Sale
Common Stock
2015-07-01$11.66/sh−7,262$84,675→ 322,250 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2014.